Geron Corporation Gains 92%

Fri, Mar 15, 2024 at 07:15 PM

Geron Corporation (GERN:NASDAQ) shot up at $3.36, representing a gain of 92%. On Fri, Mar 15, 2024, GERN:NASDAQ hit a New 2-Week High of $3.36. The stock got featured on our News Catalysts scanner on Fri, Mar 15, 2024 at 06:00 PM in the 'BIOTECH' category. From Fri, Mar 01, 2024, the stock recorded 40.00% Up Days and 27.27% Green Days

About Geron Corporation (GERN:NASDAQ)

Geron Corp is a biopharmaceutical company. It supports the clinical stage development of a telomerase inhibitor, imetelstat.

Top 10 Gainers:

Verb Technology Company, Inc. (VERB:NASDAQ), 215.86%
Geron Corporation (GERN:NASDAQ), 92%
LianBio (LIAN:NASDAQ), 83.05%
Cardlytics, Inc. (CDLX:NASDAQ), 77.15%
JetAI Inc Com (JTAI:NASDAQ), 59.72%
Chijet Motor Company Inc. (CJET:NASDAQ), 52.17%
Canoo Inc. (GOEV:NASDAQ), 48.09%
P3 Health Partners Inc. (PIII:NASDAQ), 44.33%
Outlook Therapeutics, Inc. (OTLK:NASDAQ), 43.8%
Veritone, Inc. (VERI:NASDAQ), 42.12%